Latest Pharma Insights
Strategic Intent: The Rise Of Mid-Cap Dealmakers
In this episode of Strategic Intent, Scrip’s Jessica Merrill unpacks how biopharma’s small-to-mid-cap players are stepping up as serious acquirers, using M&A to extend growth beyond their first commercial successes.
In Vivo - August 18, 2026
In this episode of Strategic Intent, Scrip’s Jessica Merrill unpacks how biopharma’s small-to-mid-cap players are stepping up as serious acquirers, using M&A to extend growth beyond their first commercial successes.
In Vivo - August 18, 2026
Sumitomo Hit By Second Gotham Broadside Over CiRA Claims
Japanese company faces fresh attack from US investment group questioning its relationship with a high-profile cell therapy research center and Nobel Laureate in Japan.
Scrip - August 18, 2026
Japanese company faces fresh attack from US investment group questioning its relationship with a high-profile cell therapy research center and Nobel Laureate in Japan.
Scrip - August 18, 2026
US Cosmetics Industry Pushes Back on China’s Trade-Busting GMP Certificate Requirement
As US regulators develop a trade board to manage bilateral trade with China, the US cosmetics industry is looking for solutions to cosmetics regulatory differences between the countries.
HBW Insight - August 18, 2026
As US regulators develop a trade board to manage bilateral trade with China, the US cosmetics industry is looking for solutions to cosmetics regulatory differences between the countries.
HBW Insight - August 18, 2026
Sumitomo Hit By Second Gotham Broadside Over CiRA Claims
Japanese company faces fresh attack from US investment group questioning its relationship with a high-profile cell therapy research center and Nobel Laureate in Japan.
Scrip - August 18, 2026
Japanese company faces fresh attack from US investment group questioning its relationship with a high-profile cell therapy research center and Nobel Laureate in Japan.
Scrip - August 18, 2026
Samsung Galaxy Buds Join Apple AirPods In FDA-Cleared OTC Hearing Aid Category
Samsung has received FDA clearance for the hearing aid and hearing test features on two Galaxy Buds models, making it the second company after Apple to win authorization for a software-based OTC hearing aid in the US.
Medtech Insight - August 17, 2026
Samsung has received FDA clearance for the hearing aid and hearing test features on two Galaxy Buds models, making it the second company after Apple to win authorization for a software-based OTC hearing aid in the US.
Medtech Insight - August 17, 2026
Mira Fertility Monitor’s Ad Claims Of Superiority Withdrawn On Clearblue Marketer P&G’s Challenge
National Advertising Division says Quanovate Tech withdrew numerous express claims for its Mira Fertility Monitor and Test Wands during review prompted by P&G challenge.
Medtech Insight - August 17, 2026
National Advertising Division says Quanovate Tech withdrew numerous express claims for its Mira Fertility Monitor and Test Wands during review prompted by P&G challenge.
Medtech Insight - August 17, 2026
Medtronic Bets Its Surgical AI Future On Compute, Not Just The Hugo Robot
Medtronic has unveiled Touch Surgery Aide, an NVIDIA-based platform to run AI live during surgery, with a first FDA-cleared algorithm that flags when instruments leave a surgeon's view on its Hugo robot — a foundation its digital chief says will carry years of surgical AI.
Medtech Insight - August 17, 2026
Medtronic has unveiled Touch Surgery Aide, an NVIDIA-based platform to run AI live during surgery, with a first FDA-cleared algorithm that flags when instruments leave a surgeon's view on its Hugo robot — a foundation its digital chief says will carry years of surgical AI.
Medtech Insight - August 17, 2026
Ambient AI Blurs Regulatory Line Between Record And Medical Device
New MHRA guidance hopes to clarify whether ambient scribing tools count as medical devices – but global ambiguity remains.
Medtech Insight - August 17, 2026
New MHRA guidance hopes to clarify whether ambient scribing tools count as medical devices – but global ambiguity remains.
Medtech Insight - August 17, 2026
NVIDIA Wants To Become The Software Layer Supporting Surgical Robotics
The chipmaker is positioning itself not as a robot builder but as the foundational infrastructure for AI and robotics across medtech — from edge computing to open models and simulation. NVIDIA's David Niewolny tells Medtech Insight why the next race in surgical robotics will be won on software.
Medtech Insight - August 17, 2026
The chipmaker is positioning itself not as a robot builder but as the foundational infrastructure for AI and robotics across medtech — from edge computing to open models and simulation. NVIDIA's David Niewolny tells Medtech Insight why the next race in surgical robotics will be won on software.
Medtech Insight - August 17, 2026
US Cosmetics Industry Pushes Back on China’s Trade-Busting GMP Certificate Requirement
As US regulators develop a trade board to manage bilateral trade with China, the US cosmetics industry is looking for solutions to cosmetics regulatory differences between the countries.
HBW Insight - August 18, 2026
As US regulators develop a trade board to manage bilateral trade with China, the US cosmetics industry is looking for solutions to cosmetics regulatory differences between the countries.
HBW Insight - August 18, 2026
How To Approach GLP-1 Approvals: Anvisa Leads By Example
Five GLP-1 approvals from Anvisa are set to extend treatment options for poorly controlled type 2 diabetes mellitus patients.
Generics Bulletin - August 17, 2026
Five GLP-1 approvals from Anvisa are set to extend treatment options for poorly controlled type 2 diabetes mellitus patients.
Generics Bulletin - August 17, 2026
Fresenius Kabi Pulls US Tocilizumab Lot As Recall Count Mounts
Fresenius Kabi has recalled a US lot of Tyenne over glass particles, extending a run of nationwide quality-related recalls that has also affected morphine and famotidine products.
Generics Bulletin - August 17, 2026
Fresenius Kabi has recalled a US lot of Tyenne over glass particles, extending a run of nationwide quality-related recalls that has also affected morphine and famotidine products.
Generics Bulletin - August 17, 2026
Meloxicam Price Spike Leads UK Increases In July
Meloxicam tablets in multiple strengths led the UK’s steepest generic price rises in July, according to the latest figures from WaveData.
Generics Bulletin - August 17, 2026
Meloxicam tablets in multiple strengths led the UK’s steepest generic price rises in July, according to the latest figures from WaveData.
Generics Bulletin - August 17, 2026
Sandoz Adds Scale And Subcutaneous Option In Major Henlius Biosimilars Deal
Sandoz has struck a major expanded deal with Henlius covering up to 10 biosimilars, potentially lifting its pipeline to 46 assets as it prepares for a broader wave of biologic loss-of-exclusivity opportunities.
Generics Bulletin - August 17, 2026
Sandoz has struck a major expanded deal with Henlius covering up to 10 biosimilars, potentially lifting its pipeline to 46 assets as it prepares for a broader wave of biologic loss-of-exclusivity opportunities.
Generics Bulletin - August 17, 2026
Strategic Intent: The Rise Of Mid-Cap Dealmakers
In this episode of Strategic Intent, Scrip’s Jessica Merrill unpacks how biopharma’s small-to-mid-cap players are stepping up as serious acquirers, using M&A to extend growth beyond their first commercial successes.
In Vivo - August 18, 2026
In this episode of Strategic Intent, Scrip’s Jessica Merrill unpacks how biopharma’s small-to-mid-cap players are stepping up as serious acquirers, using M&A to extend growth beyond their first commercial successes.
In Vivo - August 18, 2026